CareDx sharpens precision medication focus with $260m Naveris acquisition
CareDx has agreed to accumulate Naveris in a deal value as much as $260m, priming the corporate to inherit a blood‑based mostly monitoring answer for...
contenta-verify-dbb69181ba63e3b7